Anokion

Developer of therapeutic proteins to treat autoimmune and allergic diseases

placeEcublens, Fribourg, Switzerland calendar_todayFounded 2010 groups30 employees language anokion.com

Registered entities

Investor mix

7 investors on record; lead investors include Celgene, Pfizer.

Investor typeCountShare
Venture capital343%
Other / undisclosed457%
Coming soon